Stay updated on SKI-G-801 Dose Study in AML Clinical Trial
Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page
- Check4 days agoChange DetectedThe displayed site revision advances from v3.7.0 to v3.7.1 while the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedThe study record page displays a 403 Forbidden message instead of its study content, with a Home link.SummaryDifference0.6%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content; the detailed study information and related sections appear to be removed or inaccessible, and the standard site footer is shown.SummaryDifference17%

- Check45 days agoChange DetectedRevision: v3.6.6 is now shown, replacing the previous v3.6.5. This indicates a small update to the study record’s versioning rather than a modification to the study data or participant information.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now displays a 500 error/An error occurred message, replacing the study record content with an unavailable-page notice. The previous study details, navigation, and related data are no longer visible on the page.SummaryDifference16%

- Check75 days agoChange DetectedNo changes are recorded in the provided data. The page content remains as listed in the study record on ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.